-
Mashup Score: 4
We talk a lot about the price of prescription drugs in the U.S. There is bipartisan support among Americans for Medicare’s ability to negotiate drug
Source: Medecision BlogCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0The ARIA approach of Value-Added Medicines: as-needed treatment in allergic rhinitis - 2 year(s) ago
Drug repurposing is one of the major fields of Value-Added Medicines. It involves the investigation and evaluation of existing drugs for new therapeutic purposes that address unmet healthcare needs. There are several unmet needs in allergic rhinitis that could be improved by drug repurposing. This could be game-changing for disease management. The current medications for allergic rhinitis are…
Categories: Allergy-Immunology, Latest HeadlinesTweet-
In Press! The #ARIA #approach of #Value- #Added #Medicines: as-needed treatment in #allergic #rhinitis https://t.co/Pt0e8EKljS
-
-
Mashup Score: 6
Amid ongoing angst over prescription drug costs, a new analysis finds the average launch price for a medicine skyrocketed 20% annually from 2008 to 2021.
Source: STATCategories: Healthcare Professionals, Latest HeadlinesTweet-
“The average launch price for a medicine skyrocketed 20% annually from $2,115 in 2008 to $180,007 in 2021.” By @pharmalot. https://t.co/NvgaD1XEX0
-
How high? Prices for newly launched medicines rose 20% annually, analysis finds.. https://t.co/IlMrwGu8HA #pharma #medicines #inflation
-
-
Mashup Score: 0
In addition to Paxlovid and Ibrance, the list includes pneumonia vaccine Prevnar 13, rheumatoid arthritis drug Xeljanz and cancer treatments Xalkori and Inlyta.
Source: www.mdedge.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
In “An Accord for a Healthier World” Pfizer will make available all its patented #medicines and vaccines at not-for-profit prices to 45 of the world’s poorest countries. https://t.co/YTPPVvZBRN https://t.co/6bwQcF0g5l
-
-
Mashup Score: 0Quantitative online survey of self-perceived knowledge and knowledge gaps of medicines research and development among Finnish general public - 2 year(s) ago
Objectives This study explored self-reported knowledge and interest to learn more about medicines research, development and health technology assessment among Finnish general public. It also aimed to define possible knowledge gaps and needs for public education regarding these topics. Design Online survey with 503 participants. The questionnaire was originally developed as a part of the Needs…
Source: BMJ OpenCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
The Finnish general public appears to have low self-reported knowledge of #medicines research and development https://t.co/Y2ZJl2ZX5E https://t.co/AWZTqMZsJV
-
-
Mashup Score: 5Medications for Opioid Overdose, Withdrawal, & Addiction | National Institute on Drug Abuse - 2 year(s) ago
Explore the different types of medications prescribed for opioid overdose, withdrawal, and addiction
Source: National Institute on Drug AbuseCategories: Addiction Medicine, Latest HeadlinesTweet-
Methadone is an opioid receptor agonist that attaches to #opioid receptors in the #brain to block withdrawal symptoms and cravings so that patients can focus on #recovery. NIDA supports #research to develop new #medicines to treat #OpioidUseDisorder. https://t.co/9fbFnm2Oql https://t.co/IDLm60RiU8
-
-
Mashup Score: 2
How do you know what medicines are worth spending your money on? Here are five so-called medicines that are a complete waste of money.
Source: Eat This Not ThatCategories: Allergy-Immunology, Latest HeadlinesTweet-
A article published recently by @EatThisNotThat "5 #Medicines That are Usually a "Waste of #Money"" cites work that has recently been published in @JACIInPractice! Read the full @EatThisNotThat article here: https://t.co/CzNfM4YaGF https://t.co/6dwqRqV21P
-
-
Mashup Score: 1Essential medicines list in national cancer control plans: a secondary analysis from a global study - 2 year(s) ago
With the advent of innovative therapeutics for and the rising costs of cancer management, low-income and middle-income countries face increasing challenges to deliver effective and sustainable health care. Understanding of how countries are selecting and prioritising essential cancer interventions is poor, including in the formulation of policies for essential medicines. We did an in-depth…
Source: The Lancet OncologyCategories: Latest Headlines, Palliative MedicineTweet-
"Our analysis found association between inclusion of a national cancer essential #medicines list & various #palliative#care strategies in cancer plans. This is a positive finding, as it can accelerate access to #opioids." Important info for advocacy! https://t.co/8q3BBx1VY5
-
-
Mashup Score: 0
Among novel agents, SGLT2 inhibitors hold particular promise for reducing complications of diabetes and meeting common price targets, particularly when used among people with established cardiovascular or kidney disease. These findings are consistent with the choice to include SGLT2 inhibitors in the WHO Essential Medicines List.
Categories: Endocrinology, Latest HeadlinesTweet-
Expanding access to newer #medicines for people with type 2 #diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis https://t.co/kVVOoia7zQ #T2D #LIMCs #HealthEconomics #globalhealth
-
-
Mashup Score: 0
Type 2 diabetes is associated with substantial financial burden to patients and health-care systems around the world. Much of this burden is attributable to chronic complications of untreated diabetes, particularly those involving the cardiovascular system, kidneys, eyes, and feet. The situation is particularly critical in low-income and middle-income countries, where access to health insurance…
Categories: Endocrinology, Latest HeadlinesTweet-
Linked Comment: Newer antidiabetic agents: at what price will they be cost effective? https://t.co/C2ZH2FP3gY #T2D #medicines #HealthEconomics #LIMCs #globalhealth https://t.co/dqcoYj7BSD
-
Thinking abt #socialdeterminants of #prescriptiondrugs, how people take #medicines in real life Learning from @DrMauricioGon on #Rxadherence https://t.co/bdKW0MhtkQ New post @Medecision Liberate #Health TY @GoodRx for session @Cureatr @AHIMA @Albertsons @WinnCompanies https://t.co/gckMsAF5OS